79
Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

  • View
    230

  • Download
    7

Embed Size (px)

Citation preview

Page 1: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Thyroid Disorders

William Harper, MD, FRCPC

Endocrinology & Metabolism

Assistant Professor of Medicine, McMaster University

Page 2: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Case 1

• 31 year old female• Somalia Canada 3 years ago• G2P1A0, 11 weeks pregnant• Well except fatigue• Hb 108, ferritin 7 (Fe and LT4 interaction?)• TSH 0.2 mU/L, FT4 7 pM• Started on LT4 0.05 TSH < 0.01 mU/L

FT4 12 pM, FT3 2.1 pM

Page 3: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Case 1

1. How would you characterize her hypothyroidism?

2. What are the ramifications of pregnancy to thyroid function/dysfunction?

Page 4: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

TSH

LowHigh

FT4 FT4 & FT3

Low

1° Hypothyroid

Low

Central Hypothyroid

TRH Stim.

Ifequivocal

MRI, etc.

High

1° Thyrotoxicosis

High

2° thyrotoxicosis

•Endo consult•FT3, rT3•MRI, α-SU

RAIU

Page 5: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

TRH Stimulation test

A) 1° HypothyroidismB) Central HypothyroidismC) EuthyroidD) 1° Thyrotoxicosis

Page 6: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Case 1

• GH, IGF-1 normal• LH, FSH, E2, progesterone, PRL normal for

pregnancy• 8 AM cortisol 345, short ACTH test normal• MRI: normal pituitary• TGAB, TPOAB negative• LT4 increased until FT4 in hi-normal range• Normal pregnancy, delivery, baby, lactation• Considering TRH stim once done breast-feeding

Page 7: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Thyroid Tests

1. Thyroid Function

2. Iodine Kinetics

3. Thyroid Structure

4. FNA

5. Thyroid Antibodies

6. Thyroglobulin

Page 8: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

T4

T3

80% (peripheral)

20%

Protein* binding + 0.03% free T4

Protein* binding + 0.3% free T3 (10-20x less than T4)

Total T4 60-155 nMTotal T3 0.7-2.1 nMT3RU/THBI 0.77-1.23

TBG 75%TBPA 15%Albumin 10%

*

Page 9: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Thyroid Function Tests

• TSH 0.4 –5.0 mU/L• Free T4 (thyroxine) 9.1 – 23.8

pM• Free T3 (triiodothyronine) 2.23-5.3

pM

Page 10: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

TSH Assay(0.4-5 mU/L)

• Early RIA < 1.0 mU/L• Thyrotoxicosis / 2º hypothyroidism

– Unable to detect lower range of normal

• Monoclonal SEN < 0.1 mU/L

• Super SEN < 0.01 mU/L

Page 11: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Case 1

1. How would you characterize her hypothyroidism?

2. What are the ramifications of pregnancy to thyroid function/dysfunction?

Page 12: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Thyroid & Pregnancy: Normal Physiology

• Increased estrogen increased TBG

• Higher total T4, T3 (normal FT4, FT3 if thyroid gland working properly)

• hCG peak end of 1st trimester, weak TSH agonist so may cause slight goitre

• Fetal thyroid starts working at 11 wks

• T4 & T3 do NOT cross placenta (or do so minimally)

• Do cross placenta: PTU, MTZ, TSH-R Ab (stim or block)

• MTZ aplasia cutis scalp defects

Page 13: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University
Page 14: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Thyroid & Pregnancy: Hypothyroidism

• Will need ~ 25% increase in LT4 during pregnancy due to increased TBG levels

• Risks: increased spont abort, HTN, preterm pregnancy, 7 IQ points for fetus (NEJM, 341(8):549-555, Aug 31, 2001)

Page 15: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

LT4 dose adjustment in Pregnancy:Need TSH at baseline & q2mos while pregnantStarting LT4: 2 ug/kg/d and check TSH q4wk until euthythyroid

TSH Dose Adjustment

TSH increased but < 10 Increase dose by 50 ug/d

TSH 10-20 Increase dose by 50-75 ug/d

TSH > 20 Increase dose by 100 ug/d

Page 16: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Thyrotoxicosis & Pregnancy

• Risks: fetal anomalies, spont abort, preterm labor, fetal hyperthyoridism, thyroid storm in labor

• No RAI ever• Rx options: ATD or 2nd trimester thyroidectomy• PTU drug of choice (avoid MTZ due to scalp

defects)• Aim to keep FT4 levels in hi normal range• OK to breast feed on PTU as does not go into

breast milk

Page 17: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Neonatal Grave’s

• Rare < 2% infants born to Graves” moms• 2 types:Transplacental trnsfr of TSH-R ab (IgG)

• Present at birth, self-limited• Rx PTU, Lugol’s, propanolol, prednisone• Prevention: TSI in mom 2nd trimester, if 5X normal then Rx

mom with PTU (crosses placenta to protect fetus) even if mom is euthyroid (can give mom LT4 which won’t cross placenta)

Child develops own TSH-R ab• Strong family hx of Grave’s• Present @ 3-6 mos• 20% mortality, persistant brain dysfunction

Page 18: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Postpartum & Thyroid

• 5% (3-16%) postpartum women (25% T1DM)• Up to 1 year postpartum (most 1-4 months)• Lymphocytic infiltration (Hashimoto’s)• Postpartum Exacerbation of all autoimmune dx• 25-50% persistant hypothyroidism• Small, diffuse, nontender goitre• Transiently thyrotoxic Hypothyroid

Page 20: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Postpartum & Thyroid

• Distinguish Thyrotoxic phase from Grave’s:• No Eye disease

• Less severe thyrotoxic, transient (repeat thyroid fn 2-3 mos)

• RAI (if not breast-feeding)

• Rx:• Hyperthyroid symptoms: atenolol 25-50 mg od

• Hypothyroid symptoms: LT4 50-100 ug/d to start» Adjust LT4 dose for symtoms and normalization TSH

» Consider withdrawal at 6-9 months

(25-50% persistent hypothyroid, hi-risk recur future preg)

Page 21: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Postpartum & Thyroid

• Postpartum depression• When studied, no association between postpartum

depression/thyroiditis• Overlapping symtoms, R/O thyroid before start

antidepressents

• Screening for Postpartum ThyroiditisHOW: TSH q3mos from 1 mos to 1 year postpartum?WHO:

– Symptoms of thyroid dysfn.– Goitre– T1DM– Postpartum thyroiditis with prior pregnancy

Page 22: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Case 2

• 47 year old female

• Concerned about weight gain over past 15 years (15 lbs). Otherwise asymptomatic

• BMI 25, Thyroid: 40 gm, rubbery firm.

• TSH 6.7 mU/L, FT4 13 pM, FT3 2.5 pM

• FHx: mother, sister – both on LT4

• Medications: “Thyrosol” (health store)

• Wondering about hypothyroidism causing her weight gain

• Read on internet about “Wilson’s Disease”

Page 23: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Case 2

1. When to treat “Subclinical” thyroid dysfunction?

2. Naturopathic thyroid remedies

3. Hypothryoidism Rx other than Levothyroxine

4. What is Wilson’s Thyroid Disease?

Page 24: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Subclincal Hypothyroidism

TSH, normal FT4

• Most asymptomatic & don’t need Rx (monitor TSH q2-5y)

• Rx Indications:– Increased risk of progression

• TSH > 10, Female > 50 y.o.

• Anti-TPO Ab titre > 1:100,000 ?

• Goitre present ?

– Dyslipidemia?• Total cholesterol (TC) 6-8% if TSH > 10 and TC > 6.2 nM

– Symptoms?

– Pregnancy, Infertility, Ovulatory Dysfn.

Page 25: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Case 2

1. When to treat “Subclinical” thyroid dysfunction?

2. Naturopathic thyroid remedies (Thyrosol)

3. Hypothryoidism Rx other than Levothyroxine

4. What is Wilson’s Thyroid Disease?

Page 26: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University
Page 27: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Hashimoto’s Disease• Most common cause of hypothyroidism in

North America (not idodine defeciency!)• Autoimmune• lymphocytic thyroiditis• Females > Males, Runs in Families• Antithyroid antibodies:

• Thyroglobulin Ab• Microsomal Ab• TSH-R Ab (block)

Page 28: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Hashimoto’s Disease

• Treatment:• Thyroid Hormone Replacement

• Levothyroxine (T4)

• T3?, T4/T3 combo?, dessicated thyroid?

• No benefit to giving iodine!• In fact, iodine may decrease hormone production

• Wolff-Chaikoff effect (lack of escape)

Page 29: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Case 2

1. When to treat “Subclinical” thyroid dysfunction?

2. Naturopathic thyroid remedies

3. Hypothryoidism Rx other than Levothyroxine

4. What is Wilson’s Thyroid Disease?

Page 30: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Treatment of Hypothyroidism

• Iodine only if iodine deficiency is the cause• Rare in North America!

• Replacement thyroid hormone medication:• T4?

• T3?

• T4 + T3 Mixture?

• Thyroid Hormone from “natural sources” ?

Page 31: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

T4

T3

85% (peripheral conversion)

15%

Protein* binding + 0.03% free T4

Protein* binding + 0.3% free T3 (10-20x less than T4)

Normal Daily Thyroid Secretion Rate:T4 = 100 ug/dayT3 = 6 ug/day

( ratio T4:T3 = 14:1 )

Page 32: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

T4 T3

Potency 1 10

Protein Bound 10-20 1

Half-Life 5-7d < 24h

Secreted by thyroid

100 ug/d 6 ug/d

Page 33: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Levothyroxine (T4)

• Synthroid (Abbott), Eltroxin (GSK)• Synthetically made• 50 ug white pill no dye (hypoallergenic)• Most commonly prescribed treatment for

hypothyroidism• No T3 (but 85% of T3 comes from T4 conversion)• All patients made euthyroid biochemically• Most (but not all) patients feel normal

Page 34: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Levothyroxine (T4)

• Average dose 1.6 ug/kg

• Age > 50-60 or cardiac disease: must start at a low dose (25 ug/d)

• Recheck thyroid hormone levels every 4-6 weeks after a dose change

• Aim for a normal TSH level

Page 35: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Levothyroxine (T4)

• Medical situations where T4 medication may be affected.

• Estrogen: Pregnancy, OCP, HRT• Need to increase T4 dose!

• Drugs that interfere with T4 absorption• Iron, Calcium

• Cholestyramine (cholesterol resin Rx)

• At least 4h between T4 and these drugs!

Page 36: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

“I still don’t feel normal on Synthroid even though my blood tests are normal.”

• Free T4, Free T3• wide range of normal

• TSH (0.4 –5.0 mU/L)• Narrow range of normal, but still a range!• Adjust dose for a lower TSH still in the normal

range?

• Tissue levels versus circulating levels?• No human studies• Rodents: High T4 and normal T3 tissue levels

Page 37: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Liothyronine (T3)

• Cytomel (Theramed)• Shorter half-life

• Fluctuating levels (i.e. need a slow-release pill)• Twice daily dosing often needed

• 10x more potent: palpitations & other cardiac side effects

• High T3 levels, low T4 levels (not physiologic either!)

Page 38: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

T3/T4 Liotrix

• Thyrolar• Combo pill of T3 and T4• Ratio of T4:T3 = 4:1 (not 14:1)• T3 still not slow release• Few small studies showing benefit

• 1999 NEJM study 33 patients• Benefit: mood & cognitive function

• Not available in Canada

Page 39: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Desiccated Thyroid (Armour)

• Desiccated powder derived from thyroids of slaughtered pigs or cows

• Vegetarian?

• Mad Cow Disease?

• Contains T4 and T3• Still no slow-release of T3• Ratio of T4:T3

• Variable

• Still not physiologic, often too high in T3 (T4:T3 = 3:1)

Page 40: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

“In an ideal world…”

• Mixed compound with T4:T3 = 14:1

• T3 component slow release formulation

• Resultant:• Normal circulating TSH, FT4, FT3

• Normal tissue levels of T4 and T3

• Good, large studies (RCTs) demonstrating clear benefit over T4 alone

Page 41: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Case 2

1. When to treat “Subclinical” thyroid dysfunction?

2. Naturopathic thyroid remedies

3. Hypothryoidism Rx other than Levothyroxine

4. What is Wilson’s Thyroid Disease?

Page 42: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

“Wilson’s Syndrome”

• Wilson’s disease: copper toxicity liver failure• “Wilson’s Syndrome”

• Dr. E. D. Wilson “discovered” this condition and named it after himself in late 1980’s

• Decreased body temperature (low normal range)

• Hypothyroid symptoms (nonspecific)

• Normal thyroid function tests

• “Impaired T4 T3 conversion”

• “Build up of reverse T3”

• Treat with “Wilson’s T3-therapy” (presumably T3)

Page 43: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Sick Euthyroid Syndrome, not Wilson’s syndrome!

Page 44: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

“Wilson’s Syndrome”

• No scientific evidence that this condition exists• No randomized trials proving safety or any benefit

of giving people T3 when their thyroid hormone levels are normal

• This condition not endorsed by:• Canadain Society of Endocrinology and Metabolism (CSEM)

• American Thyroid Association (ATA)

• Endocrine Society

Page 45: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Case 3

• 62 y male

• Afib: amiodarone, warfarin x 11 months

• 2 months: fatigue, muscle weakness, increasing dyspnea/edema, weight gain

• O/E: HR 110 irreg-irreg, appears malnourished, JVP, SOA, lung crackles

Page 46: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Case 3

• TSH < 0.05 mU/L, FT4 60 pM, FT3 24 pM

• INR 4.2, Echo: LVH, normal LV syst fn.

• RAIU 2%, Thyroid scan: no gland seen

• Rx: Methimazole 40 mg/d, lasix, aldactone, ramipril, reduced warfarin

• Cardiolgist: d/c amiodarone bisoprolol

Page 47: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Case 3

F/up @ 2 mos:

• weight loss (more muscle, less fluid)

• Resolved: Fatigue, SOB, SOA

• HR 76 irreg-irreg

• TSH < 0.05, FT4 8 pM, FT3 2.1 pM

• INR 1.5

Page 48: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Case 3

1. What is difference between thyrotoxicosis and hyperthyroidism?

2. What is “apathetic” hyperthyroidism?

3. Amiodarone induced thyrotoxicosis?

4. Thyroid & drug-interactions (warfarin)?

5. Subclinical Thyrotoxicosis?

Page 49: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

RAIU• Oral dose of I131 5 uCi (or I123 200 uCi but more $)

• Measure neck counts @ 24h (+/- 4h if suspect high turnover)

• RAIU = neck counts – bkgd (thigh counts) x 100

pill counts - bkgd

Page 50: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

RAIU

• Normal 4h RAIU = 5-15 %

• 24h RAIU:

>25% Hyperthyroid

20-25% Equivocal (check TSH)

9-20% Normal

5-9% Equivocal (check TSH)

<5% Hypothyroid

• Dependent on dietary iodine intake!

• Must be: not pregnant! (ß-hCG), no ATD x 7d, no LT4 x 4d, no large doses of iodine or radiocontrast for 2 wk (prefer 4-6 wk)

Page 51: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University
Page 52: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Thyrotoxicosis Treatment• Beta-blockers (hyperadrenergic symptoms)

• Hyperthyroidism:• Anti-thyroid Drugs

– Propylthiouracil (PTU), Methimazole

• Radioiodine Ablation

• Surgical Thyroidectomy

• Thyroiditis:• ASA, NSAIDS, +/- corticosteroids

• Iodine (high doses Wolff Chaikoff effect)

Page 53: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

“Apathetic Hyperthyroidism”• Elderly population

• Lack of tremor, diaphoresis, heat-intolerance, hyperdefecation and other classic symptoms from sympathetic over-activity

• TMNG more likely than in young (but Grave’s still most common)

• Less likely to have a goitre

• Common symptoms:• Weight loss, anorexia

• Constipation despite thyrotoxic

• Tachycardia, Afib, CHF, angina

• Cognitive Dysfunction

Page 54: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Amiodarone and Thyroid

PHYSIOLOGIC EFFECTS1) Increase iodine pool in body and therefore decrease RAIU.2) Decrease peripheral deiodination of T4 to T3.3) Decrease pituitary deiodination and therefore transient rise

in TSH for 1st 3 mos of Rx.

Amiodarone Induced Thyroid Dysfunction:• 3 months to 4 years after starting amiodarone• Hypothyroidism 8% (subclinical hypothyroidism 20%)• Thyrotoxicosis 3% (10% iodine deficiency areas)

Page 55: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Amiodarone induced Hypothyroidism

1) Increased TSH (not useful 1st 3 mos).

2) Decreased FT4

3) Decreased FT3 (not neccesary to measure)

4) More common in areas of hi iodine intake (North America) d/t Wolff Chaikoff effect.

5) Rx:• Stop amiodarone if possible.

• LT4 aim dose to keep FT4 level at high normal to slightly above normal.

• Unlike other types of hypothyroidism do NOT try to normalize TSH as this requires dose ~ 250 ug/d and clearly causes hyperthyroidism.

Page 56: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Amiodarone induced Thyrotoxicosis (AIT)

1) Decreased TSH

2) Increased FT4

3) Increased FT3 in some patients (inhibition of deiodinase)

4) More common in areas of low iodine intake (Europe) d/t Jodbasedow effect or iodine/amiodarone induced thyroid damage.

5) Two types of AIT:• Hyperthyroidism (RAIU low but measurable) – Jodbasedow, often

goitre/nodule(s)

• Thyroiditis (RAIU 0%)

6) May present without hyperthyroid symptoms and simply worsening of cardiac disorder (arrythmia, angina, CHF, etc).

Page 57: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Amiodarone induced Thyrotoxicosis (AIT)

Rx:• Stopping amiodarone may not help as amiodarone still present in body

tissue stores for months• May need amiodarone to still treat arrythmias made worse by

thyrotoxicosis• Radioactive I-131 useless d/t decreased RAIU.• Thionamide ATDs (PTU, methimazole): Rx of choice• Glucocorticoids if RAIU indicates thyroiditis & no response to ATD

• Prednisone 40 mg/d

• Surgery? Somewhat risky d/t unknown safety wrt thyroid storm & underlying heart condition that required amiodarone in the first place!

• KClO4 (potassium perchlorate)?

Page 58: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University
Page 59: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Thyroid & Drug Interactions

1) Warfarin

• T4 increases catabolism of vitamin K dependent clotting factors.

• Increase LT4/hyperthyroidism will increase sensitivity to warfarin (decrease dose).

• Decrease LT4/hypothyroidism will decrease sensitivity to warfarin (increase dose).

2) Cholestyramine

• Binds T4 & T3

• 4-5h between resin & LT4 or T3.

3) Iron or Calcium

• Also binds T4 & T3

Page 60: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Thyroid & Drug Interactions

4) Estrogens

• Increase TBG, decrease FT4 level

• Need to increase LT4 in some patients

5) Androgens/corticosteroids

• Decrease TBG, increase FT4 level

• Need to decrease LT4 in some patients

5) Diabetes

• Increase LT4/hyperthyroidism will increase insulin/OHA requirements.

• Decrease LT4/hypothyroidism will decrease insulin/OHA requirements.

Page 61: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Subclinical Hyperthyroidism

TSH, Normal FT4 and FT3

• Progression to overt hyperthyroidism low:• Men 0% per year

• Women 1.5% per year

• TMNG or toxic adenoma present 5% per year

• Indications to Rx:• Any cardiac disease (CAD, AFIB, etc.)

• Age > 60 (10 year risk AFIB 32%, 10% if normal TSH)

• TMNG or toxic adenoma

• Osteoporosis

Page 62: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Case 4

• 29 year old female, engaged to be married• T1DM• Thyroid U/S:

• 2.9 cm R lower pole• 2.0 cm L lower pole,• Many others ranging from 0.5-1.5 cm

• TSH < 0.05 mU/L, FT4 19 pM, FT3 6.9 pM• RAIU/Scan: 45% RAIU, hot nodule on Left

Page 63: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Case 4

• FNA of 3cm nodule on Right: benign

• Rx’s offered: • RAI ablation versus thyroidectomy

• Patient chose Thyroidectomy

Page 64: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Thyroid Structure

• Physical Exam

• Thyroid Ultrasound

• Thyroid Scan

Page 65: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Thyroid nodules

• U/S more sensitive than P.E., particularly for nodules that are < 1 cm or located posteriorly in the gland.

• U/S also more SEN than thyroid scan

• U/S too Sensitive?• Thyroid Incidentaloma (Carotid duplex, etc.)

Page 66: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Thyroid U/SBenign

Characteristics

Malignant Characteristics

Regular border

Halo (sonolucent rim)

Irregular border

No Halo

Hyperechoic Hypoechoic

(more vascular)

Egg shell calcification Microcalcification

N/A Intranodular vascular spots

(color doppler)

Page 67: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Thyroid Scan

Thyroid nodule: risk of malignancy 6.5%

Cold nodule16-20% malignant

“Warm” Nodule (indeterminant) 5% malignant

Hot NoduleTc-99m < 5% malignantI123 < 1% malignant

only 5-10% of nodules

Page 68: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Fine Needle Aspiration (FNA)

• 25G Needle, 10cc syringe

• Done in Office

• +/- Local

• 3-5 passes

• SEN 95-99% (False Negative rate 1-5%)

• SPEC > 95%

Page 69: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

FNA Results

• Nondiagnostic: repeat FNA• Benign: macrofollicular or "colloid"

adenomas, chronic autoimmune (Hashimoto's) thyroiditis

• Suspicious or Indeterminant: microfollicular or cellular adenomas (follicular neoplasm)

• Malignant

Page 70: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Benign Lesions

Page 71: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Papillary Carcinoma

FNASurgical Specimen

Page 72: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Follicular Lesions on FNA: Can’t Distinguish!

Page 73: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Thyroid NodulePalpable>15mm

TSH

Low Normalor High

Scan

HotNotHot

FNA

MalignantSuspicious(Follicular)

Benign

InsufficientSample

Repeat FNA+/- U/S guide

Clin suspicionLow

Clin suspicionHigh

TotalThyroidectomy

RAI

Hemithyroidectomywith quick section+

-Close

Rx Plummer’s•Surgery•RAI

FollowU/S q1y

Page 74: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Thyroid NodulePalpable>15mm

Incidentaloma(Size < 15mm)

Hx of XRT exposure?FHx of thyroid cancer?

Malign features on U/S?Age < 20 or > 60?Grave’s Disease?

Familial Adenomatosis Polyposis

No

FollowU/S q1y ?

YesTSH

Low Normalor High

Scan

HotNotHot

FNA

MalignantSuspicious(Follicular)

Benign

InsufficientSample

Repeat FNA+/- U/S guide

Clin suspicionLow

Clin suspicionHigh

TotalThyroidectomy

RAI

Hemithyroidectomywith quick section+

-Close

Rx Plummer’s•Surgery•RAI

FollowU/S q1y

Page 75: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Case 5

• 19 year old female• PMHx: Eating Disorder, Bulimia• Weight loss despite witnessed food intake• Tachycardia, palpitations• FHx: Hypothyroidism (mother)• No palpable goitre• TSH < 0.05 mU/L, FT4 23 pM, FT3 5.0 pM• 24h RAIU 2%, Thyroid Scan: no gland seen

Page 76: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Case 5

• TSH-R antibody negative

• Thyroglobulin < 2 ng/mL (undetectable)

Page 77: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Autoimmune Thyroid Disease

TSH-R ab stim

Graves’ Dx

(hyperthyroid)

TSH-R ab block

Thyroglobulin ab

Microsomal ab

Hashimoto’s

(hypothyroid)

Page 78: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Thyroid Antibodies

• Hashimoto’s• Thyroglobulin AB (<40 KIU/L)• Thyroid peroxidase AB (< 35 KIU/L)

• Grave’s• TSI or TSH Receptor Ab (Stim): IgG antibody• SEN 60% SPEC 90%• 2-3 month turn-around time• Indications:

» Pregnant & present or past hx Grave’s: check 2nd trimester (if hi-titre > 5X normal needs PTU as TSI crosses placenta)

» ? Euthyroid Grave’s ophthalmopathy» Alternating hyper/hypo function due to alternating Stim/Block

TSI

Page 79: Thyroid Disorders William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University

Thyroglobulin (Tg)

• Normal < 40 ng/mL• Increased in all thyroid disease• Thyrotoxicosis factitia: low or undetectable Tg• Useful for thyroid cancer surveillance post surgery

& radioiodine ablation• Not useful for thyroid cancer diagnosis• Thyroglobulin antibodies in Hashimoto’s patients

may falsely elevate or decrease thyroglobulin levels